Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
This study has been completed.
Study NCT00066248 Information provided by National Cancer Institute (NCI)
First Received: August 6, 2003 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cachexia
Leukemia
Lymphoma
Myelodysplastic Syndromes
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Lymphoma, Non-Hodgkin
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Nervous System Neoplasms
Preleukemia
Syndrome
More general conditions related to this trial
Body Weight
Body Weight Changes
Bone Marrow Diseases
Disease
Emaciation
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Nervous System Diseases
Pathologic Processes
Precancerous Conditions
Signs and Symptoms
Weight Loss
Interventions listed in this trial
cyproheptadine hydrochloride
megestrol acetate
Additional drug interventions recognized in this trial
Cyproheptadine
Megestrol
More general drug interventions related to this trial
Anti-Allergic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antipruritics
Appetite Stimulants
Central Nervous System Agents
Central Nervous System Stimulants
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Dermatologic Agents
Gastrointestinal Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Sponsors listed in this trial
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Back to top of Main Content
